Evidence map›Paper›PMID 32986516›Full record

ArticleJCO global oncology2020

Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study.

Abdul Rahman Jazieh, Hakan Akbulut, Giuseppe Curigliano, Alvaro Rogado, Abdullah Ali Alsharm, Evangelia D Razis, Layth Mula-Hussain, Hassan Errihani, Adnan Khattak, Roselle B De Guzman and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04712292 (Effects of the COVID-19 Pandemic on the Diagnosis, Treatment and Outcomes of Patients Affected by Colorectal Cancer Requiring Surgery), which is not on this map. Cited by 182 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04712292 unknown statusnot on this map

Effects of the COVID-19 Pandemic on the Diagnosis, Treatment and Outcomes of Patients Affected by Colorectal Cancer Requiring Surgery: Results From a National Multicentre Cohort Study

TypeobservationalSponsorUniversity of BolognaRan2020 to 2022Enrolled15,000ConditionsColorectal Neoplasms MalignantArmsSurgical procedure for confirmed or suspected colorectal cancer
3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Review
  10. Financial toxicity among breast cancer survivors receiving care during the pandemic.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  11. Article
  12. Article
  13. Evaluating the use of new and advanced technologies in a population-based cancer registry.Health information management : journal of the Health Information Management Association of Australia · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Abdul Rahman JaziehDepartment of Oncology, King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.ORCID 0000-0001-5465-7698
Hakan AkbulutAnkara University School of Medicine, Department of Medical Oncology, Ankara, Turkey.ORCID 0000-0003-1631-5739
Giuseppe CuriglianoEuropean Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, and University of Milan, Milan, Italy.ORCID 0000-0003-1781-2518
Alvaro RogadoFundación ECO, Madrid, Spain.ORCID 0000-0002-3403-5872
Abdullah Ali AlsharmKing Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.
Evangelia D RazisHygeia Hospital, Athens, Greece.ORCID 0000-0003-3873-2947
Layth Mula-HussainRadiation Oncology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0003-0218-7270
Hassan ErrihaniNational Institute of Oncology, Mohammed V University, Rabat, Morocco.
Adnan KhattakFiona Stanley Hospital, Perth, Western Australia, Australia.
Roselle B De GuzmanManila Central University-Filemon D. Tanchoco Medical Foundation Hospital, Caloocan City, Philippines.ORCID 0000-0002-1930-9935
Clarissa MathiasNúcleo de Oncologia da Bahia, Grupo Oncoclínicas, Salvador, Bahia, Brazil.
Mohammad Omar Farouq AlkaiyatDepartment of Oncology, King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.ORCID 0000-0003-3500-6050
Hoda JradiKing Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.
Christian RolfoUniversity of Maryland School of Medicine, Baltimore, MD.ORCID 0000-0002-5109-0267
International Research Network on COVID-19 Impact on Cancer Care

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe COVID-19 pandemic affected health care systems globally and resulted in the interruption of usual care in many health care facilities, exposing vulnerable patients with cancer to significant risks. Our study aimed to evaluate the impact of this pandemic on cancer care worldwide.

methodsWe conducted a cross-sectional study using a validated web-based questionnaire of 51 items. The questionnaire obtained information on the capacity and services offered at these centers, magnitude of disruption of care, reasons for disruption, challenges faced, interventions implemented, and the estimation of patient harm during the pandemic.

resultsA total of 356 centers from 54 countries across six continents participated between April 21 and May 8, 2020. These centers serve 716,979 new patients with cancer a year. Most of them (88.2%) reported facing challenges in delivering care during the pandemic. Although 55.34% reduced services as part of a preemptive strategy, other common reasons included an overwhelmed system (19.94%), lack of personal protective equipment (19.10%), staff shortage (17.98%), and restricted access to medications (9.83%). Missing at least one cycle of therapy by > 10% of patients was reported in 46.31% of the centers. Participants reported patient exposure to harm from interruption of cancer-specific care (36.52%) and noncancer-related care (39.04%), with some centers estimating that up to 80% of their patients were exposed to harm.

conclusionThe detrimental impact of the COVID-19 pandemic on cancer care is widespread, with varying magnitude among centers worldwide. Additional research to assess this impact at the patient level is required.

Indexed as

BetacoronavirusCancer Care FacilitiesCoronavirus InfectionsCOVID-19Cross-Sectional StudiesGlobal Burden of DiseaseHealth Services AccessibilityHumansInfection ControlInternational CooperationMedical OncologyNeoplasmsPandemicsPneumonia, ViralSARS-CoV-2Surveys and Questionnaires

Identifiers

PMID32986516
PMCPMC7529504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.